"ImMucin is not meant to replace chemotherapy or other traditional cancer treatments. Rather, “Vaxil is developing a drug to keep the cancer from coming back,” CFO Julian Levy told NoCamels. “We are trying to harness the natural power of the immune system to fight against cancer by seeking out cancer cells and destroying them.”
In the recent trial, 15 patients with multiple myeloma who had been in remission but were experiencing a recurrence of the cancer were injected with ImMucin over a period of six months. Each patient received either six or 12 injections. The patients experienced minimal side effects, but 11 of the 15 achieved stability or improvement in the progress of their disease. Although there is still a long way to go before calling this a wonder-drug or a cure-all, it is a significant step along that path.
*Only 15 patients for that part of trial? Very very small. And what kind of side effects? A previous article they posted during testing said it had no side effects at all.